Based on the information available, it is recommended to consult with a healthcare provider before receiving vaccinations while on Cosentyx (secukinumab) [1]. Cosentyx is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting a specific protein in the body (interleukin-17A) to reduce inflammation [1].

According to the Cosentyx prescribing information, there are no specific recommendations regarding vaccinations while on the medication [1]. However, it is generally recommended that live vaccines should be avoided in individuals receiving immunosuppressive therapy, including biologic agents like Cosentyx [1][2]. This is because immunosuppressive drugs can increase the risk of infection and reduce the effectiveness of vaccines [2].

Therefore, it is essential to discuss any planned vaccinations with a healthcare provider to determine the best course of action while on Cosentyx [1]. In some cases, it may be recommended to receive inactivated or non-live vaccines before starting Cosentyx or to wait until after treatment has been discontinued [1].

In summary, while there are no specific recommendations regarding vaccinations and Cosentyx, it is recommended to consult with a healthcare provider before receiving vaccinations while on the medication [1]. Live vaccines should generally be avoided in individuals receiving immunosuppressive therapy [2].

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. Available from: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
2. Vaccines and Immunizations. American College of Rheumatology. 2021. Available from: <https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Vaccines-and-Immunizations>.
3. Secukinumab. DrugPatentWatch.com. 2021. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>.